About this source
- Kind
- Regulatory or official document
- Design
- Regulatory / legislative document
- Primary or secondary
- secondary
- Retraction status
- None known
- Date checked
- 15 November 2026
Limitations
US regulatory briefing prepared for an advisory committee; it is not a final FDA determination and is not controlling for UK status. Its safety summary of the healthy-volunteer trials is FDA's reading of published papers, and its account of the 2006 phase 2 death relies on internet reports because the trial data were not published.
Cited in
Adverse events in the first trial
CJC-1295 · Research finding
LimitedAdverse-reaction reporting
CJC-1295 · Safety finding
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.